Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin and Cetuximab in Advanced Head and Neck and Colon Cancer
NCT01744340Phase 2Completed
- Start
- May 2012
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in head and neck squamous cell carcinoma (HNSCC), colorectal cancer (CRC). Started May 2012; status: completed.
02
Drugs
eribulin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01744340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01744340.